Effects of statins in patients with coronary artery spasm: A nationwide population-based study.

15 While previous shorter (<3.5 years) 37 , 38 , 39 , 40 primary prevention and randomized controlled trials with >90% of participants free of CAD failed to demonstrate the benefit of statins in major cerebrovascular events and major coronary events, they have shown only marginally significant benefits on mortality, which might be because a <5‐year follow‐up make the relevant mortality benefits unlikely to arise for the primary prevention trials.

also in 5,076 other papers